During the past decade, Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD) conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD)" #1 sponsor was "LEO Pharma" with 8 trials, followed by "Cosmetique Active International" with 1 trials sponsored, "Cryobeauty" with 1 trials sponsored, "MC2 Therapeutics" with 1 trials sponsored and "Novartis" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD)" #1 collaborator was "CEISO" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD)" are "Psoriasis Vulgaris" (5 trials), "Acne Vulgaris" (2 trials), "Skin and Connective Tissue Diseases" (2 trials), "Solar Lentigo" (1 trials) and "Sunburn" (1 trials). Many other conditions were trialed in "Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD)" in a lesser frequency.

Most popular intervention types in "Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD)" are "Drug" (10 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Daivobet® ointment" (2 trials), "Aerosol spray vehicle" (1 trials), "Betamethasone Dipropionate 0.05% Cream" (1 trials), "Betamethasone dipropionate aerosol spray" (1 trials) and "Betamethasone dipropionate in LEO 90100 Aerosol, foam, vehicle" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD)" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD), 4 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".